These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38730083)

  • 1. Seasonal variation in D2/3 dopamine receptor availability in the human brain.
    Sun L; Malén T; Tuisku J; Kaasinen V; Hietala JA; Rinne J; Nuutila P; Nummenmaa L
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3284-3291. PubMed ID: 38730083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward motivation in humans and its relationship to dopamine D
    Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A
    J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
    Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
    Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.
    Ledermann K; Jenewein J; Sprott H; Hasler G; Schnyder U; Warnock G; Johayem A; Kollias S; Buck A; Martin-Soelch C
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):320-330. PubMed ID: 26708319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between subcortical brain volume and striatal dopamine D
    Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
    Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.
    Suzuki T; Graff-Guerrero A; Uchida H; Remington G; Caravaggio F; Borlido C; Pollock B; Mulsant B; Deluca V; Ismail Z; Mamo D
    Psychopharmacology (Berl); 2013 Jul; 228(1):43-51. PubMed ID: 23417515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal Variation in the Brain μ-Opioid Receptor Availability.
    Sun L; Tang J; Liljenbäck H; Honkaniemi A; Virta J; Isojärvi J; Karjalainen T; Kantonen T; Nuutila P; Hietala J; Kaasinen V; Kalliokoski K; Hirvonen J; Scheinin H; Helin S; Eerola K; Savontaus E; Yatkin E; Rinne JO; Roivainen A; Nummenmaa L
    J Neurosci; 2021 Feb; 41(6):1265-1273. PubMed ID: 33361461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain.
    Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Wong C; Ma J; Pradhan K; Tomasi D; Thanos PK; Ferré S; Jayne M
    J Neurosci; 2008 Aug; 28(34):8454-61. PubMed ID: 18716203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D
    Ghazanfari N; van Waarde A; Doorduin J; Sijbesma JWA; Kominia M; Koelewijn M; Attia K; Vállez-García D; Willemsen ATM; Heeres A; Dierckx RAJO; Visser TJ; de Vries EFJ; Elsinga PH
    Mol Pharm; 2022 Jul; 19(7):2287-2298. PubMed ID: 35732005
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploring personality traits related to dopamine D2/3 receptor availability in striatal subregions of humans.
    Caravaggio F; Fervaha G; Chung JK; Gerretsen P; Nakajima S; Plitman E; Iwata Y; Wilson A; Graff-Guerrero A
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):644-52. PubMed ID: 26944295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic status is associated with striatal dopamine D2/D3 receptors in healthy volunteers but not in cocaine abusers.
    Wiers CE; Shokri-Kojori E; Cabrera E; Cunningham S; Wong C; Tomasi D; Wang GJ; Volkow ND
    Neurosci Lett; 2016 Mar; 617():27-31. PubMed ID: 26828302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A
    Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder.
    Wang GJ; Wiers CE; Shumay E; Tomasi D; Yuan K; Wong CT; Logan J; Fowler JS; Volkow ND
    Transl Psychiatry; 2019 Feb; 9(1):93. PubMed ID: 30770780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I; Fellows C; Janouschek H; Bröcheler A; Veselinovic T; Landvogt C; Boy C; Buchholz HG; Spreckelmeyer K; Bartenstein P; Cumming P; Hiemke C; Rösch F; Schäfer W; Wong DF; Gründer G
    J Clin Psychopharmacol; 2008 Dec; 28(6):608-17. PubMed ID: 19011428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.